Health Catalyst, Inc.
HCAT
$1.34
-$0.14-9.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -2.83% | 1.48% | 4.64% | 5.55% | 4.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.83% | 1.48% | 4.64% | 5.55% | 4.88% |
| Cost of Revenue | -10.92% | -5.03% | 2.07% | 5.29% | 4.18% |
| Gross Profit | 6.70% | 9.06% | 7.63% | 5.84% | 5.72% |
| SG&A Expenses | -6.07% | -4.91% | -5.96% | -10.45% | -14.98% |
| Depreciation & Amortization | 16.35% | 21.89% | 15.47% | 8.58% | 3.53% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.44% | -4.09% | -1.14% | -1.94% | -4.91% |
| Operating Income | 42.67% | 34.90% | 28.30% | 32.04% | 39.39% |
| Income Before Tax | -266.01% | -156.27% | -34.52% | -15.82% | 31.31% |
| Income Tax Expenses | 110.34% | 115.02% | 745.64% | 15.84% | 8.75% |
| Earnings from Continuing Operations | -265.08% | -156.07% | -35.99% | -15.82% | 31.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -265.08% | -156.07% | -35.99% | -15.82% | 31.16% |
| EBIT | 42.67% | 34.90% | 28.30% | 32.04% | 39.39% |
| EBITDA | 143.98% | 108.00% | 69.51% | 61.01% | 64.78% |
| EPS Basic | -223.35% | -119.42% | -17.17% | -0.98% | 37.88% |
| Normalized Basic EPS | 26.23% | 17.18% | 9.89% | 15.16% | 31.86% |
| EPS Diluted | -223.35% | -119.42% | -17.17% | -0.98% | 37.88% |
| Normalized Diluted EPS | 26.23% | 17.18% | 9.89% | 15.16% | 31.86% |
| Average Basic Shares Outstanding | 13.13% | 16.14% | 14.89% | 12.46% | 9.58% |
| Average Diluted Shares Outstanding | 13.13% | 16.14% | 14.89% | 12.46% | 9.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |